| 1 day | -2.54% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 2018-06-26 | |
Mark Oki
DFI | Director of Finance/CFO | 57 | - |
Margaret Cabano
COO | Chief Operating Officer | - | 2004-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 58 | 2018-06-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/19/21 | Issuer sale | Director | 204,808 | 0.4116% | ||
| 3/19/21 | Issuer sale | Director | 105,616 | 0.2123% | ||
| 3/19/21 | Issuer sale | Chief Financial Officer | 781,668 | 1.5709% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.54% | +24.18% | - | - | 49.26M | ||
| -0.61% | -3.43% | +36.07% | +115.04% | 1,019B | ||
| -1.02% | -5.60% | +35.72% | +64.63% | 617B | ||
| +1.11% | -0.58% | +12.36% | +77.95% | 464B | ||
| +0.34% | -3.01% | +61.79% | +41.24% | 356B | ||
| +0.03% | -2.81% | +19.76% | +40.01% | 333B | ||
| +0.89% | -3.53% | +10.70% | +34.27% | 267B | ||
| +0.19% | -4.85% | -6.60% | +9.03% | 244B | ||
| -1.04% | -2.79% | +35.30% | +51.84% | 218B | ||
| -1.87% | -4.10% | +28.44% | +93.66% | 179B | ||
| Average | -0.46% | -3.54% | +25.95% | +58.63% | 410.8B | |
| Weighted average by Cap. | -0.25% | -3.54% | +28.98% | +70.52% |
Employees
213
Sector
Pharmaceuticals
















